RAPP
NASDAQ · Pharmaceuticals
Rapport Therapeutics Inc
$38.04
-1.89 (-4.73%)
Open$39.97
Previous Close$39.93
Day High$40.80
Day Low$37.11
52W High$42.27
52W Low$7.73
Volume—
Avg Volume325.0K
Market Cap1.91B
P/E Ratio—
EPS$-2.86
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+18.8% upside
Current
$38.04
$38.04
Target
$45.18
$45.18
$32.24
$45.18 avg
$61.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 234.18M | 211.21M | 206.84M |
| Net Income | 54.92M | 48.45M | 43.47M |
| Profit Margin | 23.5% | 22.9% | 21.0% |
| EBITDA | 80.71M | 80.88M | 78.48M |
| Free Cash Flow | 32.46M | 39.08M | 24.42M |
| Rev Growth | +10.7% | -0.4% | +18.1% |
| Debt/Equity | 0.72 | 0.64 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |